Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.
about
Pathogen inactivation technologies for cellular blood components: an updateAdvancing Public Health Using Regulatory Science to Enhance Development and Regulation of Medical Products: Food and Drug Administration Research at the Center for Biologics Evaluation and ResearchDengue in the context of "safe blood" and global epidemiology: to screen or not to screen?The cobas® 6800/8800 System: a new era of automation in molecular diagnostics.
P2860
Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advancing risk assessment for ...... ceedings of a public workshop.
@en
type
label
Advancing risk assessment for ...... ceedings of a public workshop.
@en
prefLabel
Advancing risk assessment for ...... ceedings of a public workshop.
@en
P2093
P2860
P1433
P1476
Advancing risk assessment for ...... ceedings of a public workshop.
@en
P2093
Alan E Williams
Brian S Custer
Debra A Kessler
Jay S Epstein
Lou M Gallagher
Mark O Walderhaug
Peter R Ganz
Richard A Forshee
Roger Y Dodd
P2860
P304
P356
10.1111/J.1537-2995.2012.03808.X
P577
2012-07-31T00:00:00Z